Albert David Limited (NSE:ALBERTDAVD)

Market Cap	4.80B
Revenue (ttm)	3.60B
Net Income (ttm)	404.41M
Shares Out	n/a
EPS (ttm)	70.87
PE Ratio	11.86
Forward PE	n/a
Dividend	11.50 (1.37%)
Ex-Dividend Date	Aug 2, 2024

Volume	2,792
Average Volume	8,790
Open	833.65
Previous Close	838.90
Day's Range	833.65 - 855.00
52-Week Range	762.60 - 1,753.95
Beta	0.23
RSI	46.50
Earnings Date	May 9, 2025

About Albert David

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company exports its products to Latin American, Southeast Asian, and other African countries. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1938
• Employees: 1,497
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ALBERTDAVD

Financial Performance

In 2023, Albert David's revenue was 3.62 billion, an increase of 6.12% compared to the previous year's 3.42 billion. Earnings were 754.20 million, an increase of 108.49%.